MedPath
TGA Approval

ACTEMRA tocilizumab (rch) 400 mg/20 mL injection concentrated vial (149402)

149402

ACTEMRA tocilizumab (rch) 400 mg/20 mL injection concentrated vial

Roche Products Pty Ltd

May 21, 2009

Medicine

Medicine

Active

Registered - Prescription Injectable

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/c73e523db6dd5033ee10899a1495d25e.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/6c090b9948031f5beb9f7c953b22cdd5.pdf

Active Ingredients

Tocilizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.